Latest filing published 04 Jun 2007 for SyntheMed, Inc., €2,395.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -44.7%Entry US$0.85 · Close at T+365 US$0.47
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Barry R. Frankel: trading record in brief
Barry R. Frankel discloses dealings in SyntheMed, Inc. to SEC (Form 4). The record holds 7 filings, for trades running from 31 May 2007 to 31 December 2009.
Purchases make up the whole of the open-market record (2 purchases, €3,653). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 5 share grants.
The latest filing, published on 6 January 2010, reports a share grant of €2,268 in SyntheMed, Inc. The latest purchase dates back some time: it was published 7,098 days ago, on 4 June 2007. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 27 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Barry R. Frankel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,500 shares@ US$0.92Common StockSEC:0001252877-07-000002:0Canonical exit: 29 Aug 2007 (T+90)
- 1,700 shares@ US$1.00Common StockSEC:0001252877-07-000002:1Canonical exit: 2 Sept 2007 (T+90)
2 of 2 declarations